MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Nephros DPO Ratio 2011-2025 | NEPH
Annual DPO Ratio Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.5 | 72.2 | 70 | 42.3 | 82.4 | 123 | 210 | 208 | 269 | 555 | 436 | 1.18 K | 77 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.18 K | 42.3 | 260 |
Quarterly DPO Ratio Nephros
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 38.7 | 33.4 | 31.9 | - | 51.9 | 77.4 | 67.9 | - | 32.6 | 31.8 | 42 | - | 60.7 | 72.4 | 92 | - | 65.2 | 73.4 | 36.5 | - | 43.1 | 56.6 | 60.8 | - | 68.6 | 92.9 | 106 | - | 98.8 | 142 | 150 | - | 207 | 233 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 233 | 31.8 | 79.5 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
130 | $ 24.56 | 0.7 % | $ 1.13 B |  USA |
 |
Baxter International
BAX
|
50.7 | $ 19.52 | 1.93 % | $ 9.96 B | USA |
 |
Becton, Dickinson and Company
BDX
|
59.3 | $ 200.48 | -0.23 % | $ 57.7 B | USA |
 |
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
73.7 | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
47.4 | $ 0.71 | -4.45 % | $ 30.1 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
34.9 | $ 148.28 | -0.1 % | $ 3.62 B | USA |
 |
iRhythm Technologies
IRTC
|
12.6 | $ 170.21 | 0.82 % | $ 5.31 B | USA |
 |
Alcon
ALC
|
63.6 | $ 79.15 | 0.43 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
81.2 | $ 41.07 | -3.09 % | $ 1.93 B | USA |
 |
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
279 | $ 4.85 | 2.11 % | $ 26.7 K | USA |
 |
Repro Med Systems
KRMD
|
52 | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
96.2 | $ 13.42 | 2.13 % | $ 548 M | USA |
 |
The Cooper Companies
COO
|
72.6 | $ 81.36 | -0.88 % | $ 16.2 B | USA |
 |
LeMaitre Vascular
LMAT
|
14.5 | $ 83.04 | -1.14 % | $ 1.86 B | USA |
 |
Glaukos Corporation
GKOS
|
67.2 | $ 111.73 | 2.6 % | $ 5.41 B | USA |
 |
Masimo Corporation
MASI
|
84.4 | $ 137.35 | -0.72 % | $ 7.32 B | USA |
 |
Haemonetics Corporation
HAE
|
41.9 | $ 80.24 | -3.89 % | $ 4.04 B | USA |
 |
InfuSystem Holdings
INFU
|
62.5 | $ 9.22 | -0.27 % | $ 190 M | USA |
 |
Merit Medical Systems
MMSI
|
34.4 | $ 86.49 | -0.24 % | $ 5.04 B | USA |
 |
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
25.7 | $ 559.7 | 3.2 % | $ 199 B | USA |
 |
OraSure Technologies
OSUR
|
36.6 | $ 2.49 | - | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
52.9 | $ 2.23 | -7.65 % | $ 22.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
36.5 | $ 0.36 | -7.4 % | $ 28.7 M | USA |
 |
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
34.9 | $ 251.67 | -0.27 % | $ 36.8 B | USA |
 |
Envista Holdings Corporation
NVST
|
56.8 | $ 22.07 | 0.46 % | $ 3.8 B | USA |
 |
Pro-Dex
PDEX
|
35.4 | $ 44.0 | 1.43 % | $ 145 M | USA |
 |
STAAR Surgical Company
STAA
|
74.3 | $ 23.49 | -2.65 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
31.8 | $ 253.98 | 0.82 % | $ 25 B | USA |
 |
Stereotaxis
STXS
|
99 | $ 2.35 | -1.05 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
68.4 | $ 14.04 | -1.4 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
547 | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
24.3 | $ 160.09 | 1.72 % | $ 8.92 M | USA |
 |
Utah Medical Products
UTMD
|
18 | $ 57.54 | -0.96 % | $ 209 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
54.3 | $ 11.43 | -1.21 % | $ 2.32 B | USA |
 |
Retractable Technologies
RVP
|
48.6 | $ 0.84 | 1.99 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
37.1 | $ 126.88 | 0.17 % | $ 5.94 B | USA |
 |
West Pharmaceutical Services
WST
|
46.4 | $ 271.82 | 1.6 % | $ 19.8 B | USA |